Visualization: Trial Start Analysis
We analyzed industry-sponsored, interventional trials registered on ClinicalTrials.gov from 2020 to 2024, focusing specifically on Phase 2 and Phase 3 trial starts — the most resource-intensive stages in drug development.
But we didn’t just look at raw volume. We ranked the top 15 sponsors by their 2024 activity and visualized their trends over the past five years.
Presentation: Unveiling the Clinical Trial Ecosystem